We observed MGMT promoter methylation in IDH-mutant astrocytomas of CNS WHO grade 2 less frequently than in CNS WHO grade 3 or 4 tumors, a finding which might contribute to the lack of prognostic association of the MGMT status. Here, MGMT is linked to astrocytoma (excluding glioblastoma).